Arash Fereydooni

Arash Fereydooni

Auto-generated profile, based on publicly available information

Arash Fereydooni

Division of Vascular and Endovascular Surgery, Department of Surgery, Stanford University, Stanford, CA

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 October 2019 in Vascular Medicine
Verified
Journal Article
Closed access
PDF file
AFArash Fereydooni
Arash Fereydooni
JGJolanta Gorecka
Jolanta Gorecka
ADAlan Dardik
Alan Dardik
Critical limb ischemia represents the advanced stage of peripheral artery disease, a health problem with increasing prevalence. Critical limb ischemia is associated with significant mortality, limb loss, pain, and diminished health-related quality of life. Public awareness and early diagnosis are necessary for an effective treatment with early risk factor modification, smoking cessation, and exercise therapy. Herein, we present an overview of the epidemiology as well as the clinical stages of the disease, and estimate that there are 6.5 million patients with critical limb ischemia in the US, Europe, and Japan based on global population-based studies. At least 75% of these patients, accounting for approximately 4.8 million patients, are amenable to endovascular therapy.

1 January 2020 in JVS-Vascular Science
Verified
Journal Article
Open access
YMYutaka Matsubara
Yutaka Matsubara
GKGathe Kiwan
Gathe Kiwan
AFArash Fereydooni
Arash Fereydooni
JLJohn Langford
John Langford
ADAlan Dardik
Alan Dardik
Patients with end-stage renal failure depend on hemodialysis indefinitely without renal transplantation, requiring a long-term patent vascular access. While the arteriovenous fistula (AVF) remains the preferred vascular access for hemodialysis because of its longer patency and fewer complications compared with other vascular accesses, the primary patency of AVF is only 50–60%, presenting a clinical need for improvement. AVF mature by developing a thickened vascular wall and increased diameter to adapt to arterial blood pressure and flow volume. Inflammation plays a critical role during vascular remodeling and fistula maturation; increased shear stress triggers infiltration of T-cells and macrophages that initiate inflammation, with involvement of several different subsets of T-cells and macrophages. We review the literature describing distinct roles of the various subsets of T-cells and macrophages during vascular remodeling. Immunosuppression with sirolimus or prednisolone reduces neointimal hyperplasia during AVF maturation, suggesting novel approaches to enhance vascular remodeling. However, M2 macrophages and CD4+ T-cells play essential roles during AVF maturation, suggesting that total immunosuppression may suppress adaptive vascular remodeling. Therefore it is likely that regulation of inflammation during fistula maturation will require a balanced approach to coordinate the various inflammatory cell subsets. Advances in immunosuppressive drug development and delivery systems may allow for more targeted regulation of inflammation to improve vascular remodeling and enhance AVF maturation.

1 January 2020 in JVS-Vascular Science
Verified
Journal Article
Open access
TKTambudzai Kudze
Tambudzai Kudze
SOShun Ono
Shun Ono
AFArash Fereydooni
Arash Fereydooni
LGLuis Gonzalez
Luis Gonzalez
TIToshihiko Isaji
Toshihiko Isaji
ADAlan Dardik
Alan Dardik
The arteriovenous fistula (AVF) is the preferred method of dialysis access because of its proven superior long-term outcomes.However, women havelower rates of AVF patency andutilizationthan men.We used a novel mouseAVF model that recapitulates human AVF maturation to determine whether there are differences in AVF patency in female and male mice. Aortocaval fistulas were created in female and male C57BL/6 mice (9–10 weeks). At days 0, 3, 7, and 21, infrarenal inferior vena cava (IVC) and aortic diameters and flow velocity were monitored by Doppler ultrasound and used to calculate the vessel diameter, blood flow, and shear stress. AVF were harvested, and expression of proteins was examined by proteomic analysis and immunofluorescence and of messenger RNA by quantitative polymerase chain reaction analysis. At baseline, female mice weighed less and had lower IVC velocity and smaller magnitudes of shear stress, but there was no significant difference in IVC diameter and thickness. After AVF creation, both female and male mice had similar IVC dilation and thickening with no significant differences in IVC wall thickness at day 21. However, female mice had diminished AVF patency by day 42 (25.7% vs 64.3%; P = .039). During fistula remodeling, female mice had lower IVC mean velocity and shear stress magnitude and increased spectral broadening (days 0–21). Messenger RNA and protein expression of Krüppel-like factor 2, endothelial nitric oxide synthase, and vascular cell adhesion molecule 1 was similar at baseline in female and male mice but increased in the AVF only in male mice but not in female mice (day 21). Proteomic analysis of female and male mice detected 56 proteins expressed at significantly higher levels in the IVC of female mice and 67 proteins expressed at significantly higher levels in the IVC of male mice (day 7); function-specific analysis showed that the IVC of male mice overexpressed proteins that belong to pathways implicated in the regulation of vascular function, thrombosis, response to flow, and vascular remodeling. AVF in female mice have diminished patency, preceded by lower velocity, reduced magnitudes of shear stress, and less laminar flow during remodeling. There is also sex-specific differential expression of proteins involved in thrombosis, response to laminar flow, inflammation, and proliferation. These findings suggest that hemodynamic changes during fistula maturation may play an important role underlying the diminished rates of AVF utilization in women. Women have lower rates of arteriovenous fistula (AVF) utilization than men. Using a mouse AVF model that recapitulates human AVF maturation, we show that female mice have similar AVF remodeling but diminished patency. AVF remodeling in female mice is associated with reduced shear stress and laminar flow; lack of increased transcription and translation of several anti-inflammatory, antiproliferative, and laminar flow response proteins (endothelial nitric oxide synthase, Krüppel-like factor 2, and vascular cell adhesion molecule 1); and different patterns of expression of pathways that regulate thrombosis and venous remodeling. Identifying downstream targets involved in these mechanisms may improve AVF outcomes in female patients.

5 June 2020 in Annals of Vascular Surgery
Verified
Journal Article
Closed access
PDF file
HBHalbert Bai
Halbert Bai
AFArash Fereydooni
Arash Fereydooni
HZHaoran Zhuo
Haoran Zhuo
YZYawei Zhang
Yawei Zhang
BTBritt H. Tonnessen
Britt H. Tonnessen
CCCassius Iyad Ochoa Chaar
Cassius Iyad Ochoa Chaar

23 May 2019 in Journal of Cell Biology
Verified
Journal Article
Open access
PDF file
XZXiao-Feng Zhang
Xiao-Feng Zhang
VAVisar Ajeti
Visar Ajeti
NTNicole Tsai
Nicole Tsai
AFArash Fereydooni
Arash Fereydooni
WBWilliam Burns
William Burns
PFPaul Forscher
Paul Forscher
Serotonin (5-HT) is known to increase the rate of growth cone advance via cofilin-dependent increases in retrograde actin network flow and nonmuscle myosin II activity. We report that myosin II activity is regulated by PKC during 5-HT responses and that PKC activity is necessary for increases in traction force normally associated with these growth responses. 5-HT simultaneously induces cofilin-dependent decreases in actin network density and PKC-dependent increases in point contact density. These reciprocal effects facilitate increases in traction force production in domains exhibiting decreased actin network density. Interestingly, when PKC activity was up-regulated, 5-HT treatments resulted in myosin II hyperactivation accompanied by catastrophic cofilin-dependent decreases in actin filament density, sudden decreases in traction force, and neurite retraction. These results reveal a synergistic relationship between cofilin and myosin II that is spatiotemporally regulated in the growth cone via mechanocatalytic effects to modulate neurite growth.

1 January 2022 in Journal of Vascular Surgery
Verified
Journal Article
Closed access
AFArash Fereydooni
Arash Fereydooni
JRJoel L. Ramirez
Joel L. Ramirez
KMKatherine L. Morrow
Katherine L. Morrow
SSSabina Sorondo
Sabina Sorondo
JLJason T. Lee
Jason T. Lee
VCVenita Chandra
Venita Chandra